U.S. Code · Título 21
Designated new animal drugs for minor use or minor species
21 U.S.C. § 360ccc–2
Office of the Law Revision Counsel · release 119-142
Se muestra el texto operativo de la sección. Las notas estatutarias y el historial de enmiendas están en la fuente oficial.
Designation
The Secretary may declare a new animal drug a “designated new animal drug” if—
Regarding the termination of a designation—
Grants and contracts for development of designated new animal drugs
For purposes of paragraph (1) of this section—
The term “qualified safety and effectiveness testing” means testing—
Exclusivity for designated new animal drugs
If an application filed pursuant to section 360b of this title or section 360ccc of this title is approved for a designated new animal drug, the Secretary may, during the 7-year exclusivity period beginning on the date of the application approval or conditional approval, approve or conditionally approve another application under section 360b of this title or section 360ccc of this title for such drug for such minor use or minor species for another applicant if—
(June 25, 1938, ch. 675, § 573, as added Pub. L. 108–282, title I, § 102(b)(4), Aug. 2, 2004, 118 Stat. 900; amended Pub. L. 114–89, § 2(a)(4), Nov. 25, 2015, 129 Stat. 700.)